Drugs / EndoCem
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07066410 | Oct 2023 → Oct 2025 overdue | pulpitis | British University In Egypt | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EndoCem | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07066410 ↗ |
| Modality | Other / unclassified | “EndoCem, a premixed calcium silicate-based cement (Maruchi, Korea)” NCT07066410 ↗ |